Fresenius Medical Care AG (Frankfurt: FME) announced that its supervisory board has reappointed Chief Financial Officer Martin Fischer for a five-year term extending until 2031. The 49-year-old executive will continue serving as a management board member of the dialysis services provider.

Michael Sen, chairman of the supervisory board, stated that Fischer has demonstrated leadership and strengthened the company's governance, transparency, and financial discipline. Sen noted Fischer's contribution to the company's transformation efforts over recent years.

CEO Helen Giza described Fischer as a trusted partner in driving organizational performance and said he has played a role in strengthening financial resilience and supporting capital allocation decisions.

Fischer joined Fresenius Medical Care after serving as head of finance for the diagnostics division at Siemens Healthineers. He holds a business informatics degree from Reutlingen University of Applied Sciences, an MBA from Friedrich Alexander University in Nuremberg, and completed a CFO program at Columbia Business School.

Fresenius Medical Care operates 3,539 dialysis clinics globally and provides dialysis treatments to approximately 290,000 patients worldwide. The company also manufactures dialysis products including machines and dialyzers. The company trades on the Frankfurt Stock Exchange and New York Stock Exchange (FMS).

The information was provided in a company press release issued May 20, 2026.